US FDA Warns Merck & Co., Inc. About Vaccine Plant Problems

May 1, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, April 30 (Reuters) - U.S. regulators have warned Merck & Co Inc about manufacturing deficiencies related to vaccine production at a company plant in West Point, Pennsylvania, according to a letter released on Wednesday.

Twitter
LinkedIn
Facebook
Email
Print

Real estate

Merck & Co. Food and Drug Administration (FDA)